Author

Jean-Jacques Fournié

Centre de Recherches en Canc

Biography

Dr Jean Jacques Fournié is completed his PhD (Biochemistry and Immunology) from Toulouse University and Post-doctoral studies at the Clinical Immunology Research Center of the University of Sydney, Australia. He was a founder of Innate Pharma, a company developing NK cell therapies for cancer. Dr. Fournié is also the Founding Director of Cancer Research Center of Toulouse, an international cancer research laboratory from INSERM, University of Toulouse 3 and CNRS, and leads the research team ‘Innovating Therapeutics Strategies in Lymphomas’ of Laboratoire d’Excellence Toulouse Cancer at Institut Universitaire du Cancer of Toulouse-Oncopole, France.
Title
Cited by
Year
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes
G Pizzolato, H Kaminski, M Tosolini, DM Franchini, F Pont, F Martins, ...Proceedings of the National Academy of Sciences 116 (24), 11906-11915, 2019201
136
2019
Single-Cell Signature Explorer for comprehensive visualization of single cell signatures across scRNA-seq datasets
F Pont, M Tosolini, JJ FourniéNucleic acids research 47 (21), e133-e133, 2019201
81
2019
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells
CC Balança, A Salvioni, CM Scarlata, M Michelas, C Martinez-Gomez, ...JCI insight 6 (2), 2021202
55
2021
Latest advances in targeting the tumor microenvironment for tumor suppression
C Laplagne, M Domagala, A Le Naour, C Quemerais, D Hamel, ...International journal of molecular sciences 20 (19), 4719, 2019201
52
2019
Regulatory mechanisms of inhibitory immune checkpoint receptors expression
N Curdy, O Lanvin, C Laurent, JJ Fournié, DM FranchiniTrends in cell biology 29 (10), 777-790, 2019201
45
2019
GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-κB-dependent mechanism
L Mondragón, R Mhaidly, GM De Donatis, M Tosolini, P Dao, AR Martin, ...Cancer Cell 36 (3), 268-287. e10, 2019201
37
2019
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
C Bosc, E Saland, A Bousard, N Gadaud, M Sabatier, G Cognet, T Farge, ...Nature Cancer 2 (11), 1204-1223, 2021202
37
2021
Cancer cells resistance shaping by tumor infiltrating myeloid cells
M Domagala, C Laplagne, E Leveque, C Laurent, JJ Fournié, E Espinosa, ...Cancers 13 (2), 165, 2021202
24
2021
A tridimensional model for NK cell-mediated ADCC of follicular lymphoma
E Decaup, C Rossi, P Gravelle, C Laurent, J Bordenave, M Tosolini, ...Frontiers in Immunology 10, 1943, 2019201
22
2019
Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry
JP Cerapio, A Marchio, L Cano, I López, JJ Fournié, B Régnault, ...Oncotarget 12 (5), 475, 2021202
19
2021
Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma
C Rossi, M Tosolini, P Gravelle, S Pericart, S Kanoun, S Evrard, ...Haematologica 107 (1), 221, 2022202
18
2022
Cancer cell adaptability: turning ribonucleoprotein granules into targets
M Lavalée, N Curdy, C Laurent, JJ Fournié, DM FranchiniTrends in Cancer 7 (10), 902-915, 2021202
17
2021
Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins
C Laplagne, L Ligat, J Foote, F Lopez, JJ Fournié, C Laurent, S Valitutti, ...Cellular & Molecular Immunology 18 (8), 1861-1870, 2021202
17
2021
Dual relief of T-lymphocyte proliferation and effector function underlies response to PD-1 blockade in epithelial malignancies
CC Balança, CM Scarlata, M Michelas, C Devaud, V Sarradin, C Franchet, ...Cancer Immunology Research 8 (7), 869-882, 2020202
17
2020
PTMselect: Optimization of protein modifications discovery by mass spectrometry
RT Perchey, L Tonini, M Tosolini, JJ Fournié, F Lopez, A Besson, F PontScientific Reports 9 (1), 4181, 2019201
16
2019
Deciphering human γδ T cell response in cancer: Lessons from tumor‐infiltrating γδ T cells
E Lo Presti, F Dieli, JJ Fourniè, S MeravigliaImmunological Reviews 298 (1), 3-164, 2020202
15
2020
Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse
S Cadot, C Valle, M Tosolini, F Pont, L Largeaud, C Laurent, JJ Fournie, ...Biomarker research 8, 1-13, 2020202
14
2020
Single-cell RNAseq profiling of human γδ T lymphocytes in virus-related cancers and COVID-19 disease
JP Cerapio, M Perrier, F Pont, M Tosolini, C Laurent, S Bertani, JJ FournieViruses (11), 2212, 2021202
13
2021
Insights on TAM formation from a Boolean model of macrophage polarization based on in vitro studies
M Marku, N Verstraete, F Raynal, M Madrid-Mencía, M Domagala, ...Cancers 12 (12), 3664, 2020202
11
2020
Single-Cell Virtual Cytometer allows user-friendly and versatile analysis and visualization of multimodal single cell RNAseq datasets
F Pont, M Tosolini, Q Gao, M Perrier, M Madrid-Mencía, TS Huang, ...NAR genomics and bioinformatics 2 (2), lqaa025, 2020202
11
2020

Referred From: https://scholar.google.fr/citations?user=8wKQpF0AAAAJ&hl=fr

Cited by
Citations 14163
h-index 64
i10-index 186
Recommended Journals
Open Access Journals